[{"Assets_0_Q3_USD":66322000.0,"CommonStockSharesOutstanding_0_Q3_shares":37351562.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-16864000.0,"NetIncomeLoss_1_Q3_USD":-5392000.0,"NetIncomeLoss_3_Q3_USD":-20794000.0,"StockholdersEquity_0_Q3_USD":65088000.0,"Ticker":"PRVB","CIK":"1695357","name":"PROVENTION BIO, INC.","OfficialName":"Provention Bio Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"371519921.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]